Kaili Hu

Shanghai University of Traditional Chinese Medicine

H指数:31

被引数:4,076

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nanosized natural products for immune dysregulation: A systematic review of mechanisms, therapeutic applications, and translational challenges

纳米级天然产物用于免疫失调：机制、治疗应用和转化挑战的系统综述

Phytomedicine

IF8.3

2025-11-220

PRE

Precision targeted cancer-associated fibroblast nano-regulator enhanced chemo-immunotherapy for triple-negative breast cancer

靶向癌相关成纤维细胞的精确纳米调控器增强的化疗-免疫联合疗法用于三阴性乳腺癌

Biomaterials

IF12.9

2025-09-040

PRE

Penetrative Biomimetic Nanovehicle Boosts Immunotherapy in Triple-Negative Breast Cancer via SOS1 Blockade

穿透性仿生纳米载体通过SOS1阻滞增强三阴性乳腺癌的免疫治疗

Asian Journal of Pharmaceutical Sciences

IF11.9

2025-05-020

OAAI

Chemotaxis-driven hybrid liposomes recover intestinal homeostasis for targeted colitis therapy

趋化性驱动的杂化脂质体恢复肠道稳态，用于靶向性结肠炎治疗

JOURNAL OF CONTROLLED RELEASE

IF11.5

2025-04-010

PRE

Rational Design of Bioinspired Lipoprotein System to Improve Penetration in Colorectal Peritoneal Metastases

基于生物启发脂蛋白系统的理性设计以改善在结直肠腹膜转移瘤中的渗透性

NANO LETTERS

IF9.1

2025-03-190

PRE

The emerging role of microglia in the development and therapy of multiple sclerosis

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-12-010

PRE

Study on the preparation of stabilizer-free silymarin nanocrystals and its oral absorption mechanisms

international journal of pharmaceutics

IF6.4

2024-12-011

OAAI

Gastrodin Liposomes Block Crosstalk between Astrocytes and Glioma Cells via Downregulating Cx43 to Improve Antiglioblastoma Efficacy of Temozolomide

BIOCONJUGATE CHEMISTRY

IF3.9

2024-08-241

PRE

Vesicular drug delivery systems for oral absorption enhancement

CHINESE CHEMICAL LETTERS

IF8.9

2024-07-015

PRE

Biomimetic nano-spears for CAFs-targeting: splintered three shields with enhanced cisplatin anti-TNBC efficiency

JOURNAL OF CONTROLLED RELEASE

IF11.5

2024-06-010

PRE

Nanomedicines for reversing immunosuppressive microenvironment of hepatocellular carcinoma

纳米药物逆转肝癌免疫抑制微环境的研究

BIOMATERIALS

IF12.9

2024-04-015

PRE

Intranasal delivery of Borneol/R8dGR peptide modified PLGA nanoparticles co-loaded with curcumin and cisplatin alleviate hypoxia in pediatric brainstem glioma which improves the synergistic therapy

JOURNAL OF CONTROLLED RELEASE

IF11.5

2023-10-015

PRE

Nose to brain delivery of Astragaloside IV by β-Asarone modified chitosan nanoparticles for multiple sclerosis therapy

黄芪甲苷经 β-Asarone修饰壳聚糖纳米粒鼻转脑给药治疗多发性硬化

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2023-09-0111

PRE

Natural Products for the Immunotherapy of Glioma

用于神经胶质瘤免疫治疗的天然产物

NUTRIENTS

IF5

2023-06-1914

OAAI

Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment

ADVANCED SCIENCE

IF14.1

2023-01-0419

OAAI

The Role of CD4+ T Cells in the Immunotherapy of Brain Disease by Secreting Different Cytokines

CD4 T细胞分泌不同细胞因子在脑疾病免疫治疗中的作用

JOURNAL OF NEUROIMMUNE PHARMACOLOGY

IF3.5

2022-11-295

PRE

Experimental murine models of brainstem gliomas

DRUG DISCOVERY TODAY

IF7.5

2022-05-013

PRE

Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19)

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-04-015

OAAI

Functional Metabolomics Reveals that Astragalus Polysaccharides Improve Lipids Metabolism through Microbial Metabolite 2-Hydroxybutyric Acid in Obese Mice

ENGINEERING

IF11.6

2022-02-0121

OAAI

Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health

传统草药和纳米医学: 融合学科以提高治疗效果和人类健康

ADVANCED DRUG DELIVERY REVIEWS

IF17.6

2021-11-0195

PREAI

Kaili Hu

个人简介

教育背景

工作经历

荣誉奖项

研究方向